Table 1.

Comparison of baseline demographics and clinical characteristics of the study patients.

Variables	OLZ (N = 405)	RIS (N = 276)	QUE (N = 115)	p-value
Age at Baseline	41.8(10.5)	40.4(12.1)	39.62(10.9)	0.0826
Age of Illness Onset	19.5(8.3)	20.0(9.2)	21.0(9.9)	0.2516
Gender (% Male)	61.7%(n = 250)	54.7%(n = 151)	47.8%(n = 55)	0.0165
Race (%)				0.2584
White	46.7%(n = 189)	45.3%(n = 125)	53.9%(n = 62)
Black	41.2%(n = 167)	36.6%(n = 101)	33.9%(n = 39)
Hispanic	8.9%(n = 36)	13.8%(n = 38)	8.7%(n = 10)
Others	3.2%(n = 13)	4.4%(n = 12)	3.5%(n = 4)
Insurance (%)				0.5837
Medicaid/Medicare	83.0%(n = 327)	80.2%(n = 218)	83.9%(n = 94)
Champus/VA	6.8%(n = 27)	5.2%(n = 14)	2.7%(n = 3)
Private/HMO	2.3%(n = 9)	4.0%(n = 11)	2.7%(n = 3)
Other Insurance	1.0%(n = 4)	1.5%(n = 4)	1.8%(n = 2)
No Insurance	6.8%(n = 27)	9.2%(n = 25)	8.9%(n = 10)
Marriage Status (% single)	63.0%(n = 254)	57.8%(n = 129)	61.7%(n = 71)	0.3885
Education (% High School or Less)	71.6%(n = 287)	63.9%(n = 175)	67.3%(n = 76)	0.1046
Comorbidity
Diagnosis of Substance use (%)	30.9%(n = 125)	29.4%(n = 81)	19.1%(n = 22)	0.0467
Diagnosis of Mental Retardation (%)	7.6%(n = 31)	6.2%(n = 17)	8.7%(n = 10)	0.626
Diagnosis of Personality (%)	18.3%(n = 74)	13.0%(n = 36)	20.9%(n = 24)	0.0925
Diagnosis of Borderline (%)	2.7%(n = 11)	2.9%(n = 8)	5.2%(n = 6)	0.3827
Diagnosis of Mental Retardation or Borderline (%)	10.4%(n = 42)	8.3%(n = 23)	13.0%(n = 15)	0.3529
Schizoaffective disorder diagnosis at enrollment (%)	39.6%(n = 132)	33.3%(n = 92)	40%(n = 46)	0.3239
Hospitalization Status on Initiation day (%)	12.8%(n = 52)	22.1%(n = 61)	13.9%(n = 16)	0.0043
MADRS Score at Enrollment	15.6(10.3)	15.5(11.4)	16.3(11.4)	0.8006
PANSS Total at Enrollment	73.2(18.4)	72.9(18.9)	73.6(17.74)	0.9451
Total days on index drug post 1 year after initiation	280(121)	260(134)	239(136)	0.0048
Total days CONTINUOUSLY on index drug post 1-year after initiation	272(129)	250(1431)	225(147)	0.0023